Synergic Effects of Physical Activity and Probiotic on Gut Immune System and Quality of Life of Breast Cancer Survivors.
- Conditions
- Breast Cancer Females
- Interventions
- Dietary Supplement: Probiotic groupOther: Physical Exercise and probiotic groupDietary Supplement: Placebo group
- Registration Number
- NCT03760653
- Lead Sponsor
- Universidad Europea de Madrid
- Brief Summary
Physical exercise along with gut microbiota improvement -because of probiotic intake- can improve the quality of life and immune system in breast cancer survivors. This is achieved because exercise improves the muscle mass in cancer patients (often reduced by treatment and/or inactivity), together with the gut microbiota improvement, this stimulates the inmune system function, improving the quality of life of these patients.
- Detailed Description
The aim of this study is to determine the effects of physical exercise together with the supplementation of a probiotic on gut microbiota balance, the gut immune system and quality of life (intended as functional and muscular capacity, physical qualities and emotional state) in breast cancer survivors .
A randomized controlled pilot study has been designed in three parallel groups. Breast cancer survivors will be randomly assigned to each of the 3 groups: a) probiotic supplementation + supervised combined physical exercise (PEF), b) probiotic supplementation and habitual sedentary lifestyle (P), and c) control group will follow their usual lifestyle and will receive a placebo (C).
The exercise intervention will last 12 weeks. It will include three weekly sessions of programmed physical exercise of \~ 60 min duration (combined training). The exercise program will be individualized and will follow the rules of the world reference institutions for aerobic training. Each session will be held in a qualified fitness center and it will be supervised and individualized for each subject by professional experts .The two supplemented groups will take 3 capsules (Lactobacillus rhamnosus, Lactobacillus paracasei, Lactobacillus acidophilus, Bifidobacterium bifidum) a day (at night before bedtime) for 12 weeks.
The variables gut microbiota, fecal levels of immunoglobulin A, cardiorespiratory capacity, anthropometry variables, lifestyle, muscular capacity, quality of life, anxiety, depression and stress levels will be analized at the beginning (baseline dose) and after 12 weeks of intervention.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
- Breast Cancer Survivors
- <18 aged.
- No chemotherapy treatment or that at least three months have passed after the last chemotherapy treatment before the beginning of the study.
- Breast cancer status: I-IV status.
- ECOG scale: 0-1.
- Normal weight.
- Extreme Diet.
- Exercise practice (at least at the doses recommended by WHO)
- Presence of heart disease
- Uncontrolled blood hypertension: (>160/90 mmHg).
- Uncontrolled metabolic disease
- Infectious chronic disease
- Uncontrolled pain
- Pregnancy or breast feeding
- Gastrointestinal disease
- Alcoholism
- Any condition that contraindicates the exercise practice in survivors cancer (fractures risk, severe leukopenia , low platelet count)
- Antibiotics intake during the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Probiotic group Probiotic group Participants will follow their usual sedentary lifestyle (i.e to practice less than 3 days a week of physical exercise, as is specified in the inclusion criteria). They will take the probiotic supplementation at the established dose. Each probiotic capsule contains Lactobacillus rhamnosus, Lactobacillus paracasei, Lactobacillus acidophilus, Bifidobacterium bifidum Physical Exercise and probiotic group Physical Exercise and probiotic group The subjects will receive 3 weekly sessions of combined exercise supervised by professionals in a specialized gym (60 minutes each one). The exercise will consist of a combination of aerobic and strength exercises involving the main muscle groups. They will take the probiotic supplementation at the established dose, 3 capsules/day before bedtime. Each probiotic capsule contains Lactobacillus rhamnosus, Lactobacillus paracasei, Lactobacillus acidophilus, Bifidobacterium bifidum. Placebo group Placebo group They will follow their sedentary lifestyle. Placebo probiotic will consist of a maltodextrin capsule.
- Primary Outcome Measures
Name Time Method Change in Quality of life of breast cancer survivors Quality of life will be analyzed at the beginning (baseline dose) and after 12 weeks of intervention Breast cancer survivors quality of life will be analyzed with the quality of life questionnaire from The European Organization for Research and Treatment of Cancer EORTC QLQ BR-23 test (a specific module for breast cancer survivors)
- Secondary Outcome Measures
Name Time Method Change in Functional capacity Functional capacity and physical quality will be analyzed at the beginning (baseline dose) and after 12 weeks of exercise intervention Dynamic fitness cardiorespiratory
Change in Body Composition Functional capacity and physical quality will be analyzed at the beginning (baseline dose) and after 12 weeks of exercise intervention Body Mass Index
Change in Muscular Capacity Muscular capacity will be analyzed at the beginning (baseline dose) and after 12 weeks of intervention. Pressure manual test will be determined
Change in Dietary habits Lifestyle will be analyzed at the beginning (baseline dose) and after 12 weeks of intervention Food Frequency Questionnaire
Change in Physical activity level Lifestyle will be analyzed at the beginning (baseline dose) and after 12 weeks of intervention Physical activity questionnaire (IPAQ) will be used
Change in Anxiety state Emotional state will be analyzed at the beginning (baseline dose) and after 12 weeks of intervention The State-Trait Anxiety Inventory (STAI)
Change in Depression state Emotional state will be analyzed at the beginning (baseline dose) and after 12 weeks of intervention Depression inventory (IDER)
Change Stress state Emotional state will be analyzed at the beginning (baseline dose) and after 12 weeks of intervention Stress coping questionnarie for oncology patients will be used
Change in Gut Microbiota Gut microbiota will be analyzed at the beginning (baseline dose) and after 12 weeks of intervention) Microbial diversity, bifidobacteria and lactobacillus percentage
Change in Immune system Immunoglobulin A levels will be analyzed at the beginning (baseline dose) and after 12 weeks of intervention Fecal immunoglobulin A levels
Trial Locations
- Locations (1)
Mar Larrosa
🇪🇸Villaviciosa de Odón, Madrid, Spain